This is the authors' abstract. We don't add key points for this paper.
Protonation of 2,3-dipyridin-2-ylquinoxaline 1 results in a significant change in the conformation of the molecule as revealed by 1H NMR and optical spectroscopies and by single crystal X-ray diffraction studies performed upon the product, 2-(3-pyridin-2-ylquinoxalin-2-yl)pyridinium hexafluorophosphate, 2. A further consequence of protonation is that the electronic properties of 2 are altered in such a way as to produce a luminescent compound, the luminescence of which is quenched by a variety of biologically and commercially relevant anions.
No takes yet. Share an insight, caveat, or question.
Kruger et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: